ANIP vs. INVA
ANIP (ANI Pharmaceuticals, Inc.) and INVA (Innoviva, Inc.) are both stocks. Both are in the Healthcare sector — ANIP in Drug Manufacturers - Specialty & Generic, INVA in Biotechnology. Over the past 10 years, ANIP returned 2.65%/yr vs 5.03%/yr for INVA. Their 0.24 correlation means their historical movements had little consistent relationship.
Performance
ANIP vs. INVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANIP achieves a 0.38% return, which is significantly lower than INVA's 4.90% return. Over the past 10 years, ANIP has underperformed INVA with an annualized return of 2.65%, while INVA has yielded a comparatively higher 5.03% annualized return.
ANIP
- 1D
- -1.48%
- 1M
- -7.89%
- 6M
- -3.19%
- YTD
- 0.38%
- 1Y
- 23.95%
- 3Y*
- 15.99%
- 5Y*
- 18.49%
- 10Y*
- 2.65%
- ALL TIME*
- -3.69%
INVA
- 1D
- -1.18%
- 1M
- -6.01%
- 6M
- 4.85%
- YTD
- 4.90%
- 1Y
- 12.56%
- 3Y*
- 16.22%
- 5Y*
- 8.14%
- 10Y*
- 5.03%
- ALL TIME*
- 1.79%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $19.71M | $22.85M | $27.70M | |
INVA Innoviva, Inc. | $12.98M | $16.47M | $18.69M |
ANIP vs. INVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ANIP ANI Pharmaceuticals, Inc. | 0.38% | 42.80% | 0.25% | 37.06% | -12.70% | 58.68% | -52.91% | 36.98% | -30.15% | 6.32% |
INVA Innoviva, Inc. | 4.90% | 15.22% | 8.17% | 21.06% | -23.19% | 39.23% | -12.50% | -18.85% | 22.97% | 32.62% |
Correlation
The correlation between ANIP and INVA is 0.30, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.30 |
Correlation (3Y) Balances recent behavior with more history. | 0.31 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.28 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.31 |
Correlation (All Time) Calculated using the full available price history since Oct 5, 2004 | 0.24 |
Fundamentals
ANIP:
$1.80B
INVA:
$1.55B
ANIP:
$4.21
INVA:
$5.93
ANIP:
18.81
INVA:
3.54
ANIP:
0.13
INVA:
0.02
ANIP:
1.83
INVA:
4.20
ANIP:
3.04
INVA:
1.23
ANIP:
$923.71M
INVA:
$424.12M
ANIP:
$486.11M
INVA:
$323.16M
ANIP:
$234.71M
INVA:
$438.91M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANIP vs. INVA — Risk / Return Rank
ANIP
INVA
ANIP vs. INVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ANI Pharmaceuticals, Inc. (ANIP) and Innoviva, Inc. (INVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ANIP | INVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.18 | ||
| Sortino ratioReturn per unit of downside risk | +0.34 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.12 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 0.88 | 0.76 | +0.12 |
| Martin ratioReturn relative to average drawdown | 1.52 | 1.78 | -0.26 |
Loading charts...
Drawdowns
ANIP vs. INVA - Drawdown Comparison
The maximum ANIP drawdown since its inception was -98.81%, which is greater than INVA's maximum drawdown of -84.32%. Use the drawdown chart below to compare losses from any high point for ANIP and INVA.
Loading charts...
Drawdown Indicators
| ANIP | INVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.81% | -84.32% | -14.49% |
Max Drawdown (1Y)Largest decline over 1 year | -28.66% | -20.32% | -8.34% |
Max Drawdown (3Y)Largest decline over 3 years | -28.66% | -23.53% | -5.13% |
Max Drawdown (5Y)Largest decline over 5 years | -59.38% | -47.01% | -12.37% |
Max Drawdown (10Y)Largest decline over 10 years | -72.96% | -59.57% | -13.39% |
Current DrawdownCurrent decline from peak | -82.39% | -34.43% | -47.96% |
Average DrawdownAverage peak-to-trough decline | -79.41% | -44.61% | -34.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.56% | 8.69% | +7.87% |
Volatility
ANIP vs. INVA - Volatility Comparison
ANI Pharmaceuticals, Inc. (ANIP) has a higher volatility of 8.46% compared to Innoviva, Inc. (INVA) at 6.96%. This indicates that ANIP's price experiences larger fluctuations and is considered to be riskier than INVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANIP | INVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.46% | 6.96% | +1.50% |
Volatility (6M)Calculated over the trailing 6-month period | 21.66% | 18.49% | +3.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.64% | 29.31% | +6.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.26% | 27.44% | +18.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.10% | 33.55% | +14.55% |
Dividends
ANIP vs. INVA - Dividend Comparison
Neither ANIP nor INVA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANIP ANI Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
INVA Innoviva, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.12% |
Financials
ANIP vs. INVA - Financials Comparison
This section allows you to compare key financial metrics between ANI Pharmaceuticals, Inc. and Innoviva, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ANIP and INVA have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANIP has higher volatility (8.46%) compared to INVA (6.96%). In terms of maximum drawdown, ANIP dropped -98.81% vs INVA's -84.32%.
ANIP currently has the higher Sharpe Ratio (0.71 vs 0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANIP and INVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer